Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Clinical Breakthroughs
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to Cardiovascular
    • Refer to Kidney Transplant
    • Refer to Neurosciences
    • Refer to Other Specialties

< BACK TO NEWS AND ONCOLOGY

August 2026

ONCOLOGY

CHAD MIRKIN, MD, RECEIVES 2027 PRIESTLEY MEDAL FROM AMERICAN CHEMICAL SOCIETY (ACS)

Northwestern University’s Chad A. Mirkin, MD, will receive the 2027 Priestley Medal from the American Chemical Society (ACS), in recognition of his distinguished service to the field of chemistry and landmark research which has transformed how chemists design, synthesize and apply nanoscale materials. It is the highest honor bestowed by the world’s largest scientific society.

A global leader in supramolecular chemistry, nanoscience and nanotechnology, Dr. Mirkin has transformed how chemists design, synthesize and apply nanoscale materials. His work has led to the discovery and development of new classes of nanomaterials, including spherical nucleic acids. These tiny nanostructures have led to life-changing diagnostic tools and therapeutics based on the principles of structural nanomedicine. They also have laid a foundation for new approaches to design and synthesize new forms of nanoscale matter through colloidal crystal engineering with DNA.

“The Priestley Medal is a signature honor for a chemist,” Dr. Mirkin says. “The list of past winners is extraordinary, including many of the scientific luminaries of the last century, like Northwestern’s Fred Basolo, who played a key role in convincing me to come to Northwestern. It further validates what we set out to do three decades ago — to transform Northwestern into a scientific powerhouse and make it the world leader in nanoscience. It is an important recognition that also encompasses the efforts of hundreds of students and postdocs and many colleagues, who have significantly contributed to our scientific projects.”

Dr. Mirkin is the George B. Rathmann Professor of Chemistry and a professor of medicine (hematology and oncology), materials science and engineering, biomedical engineering, and chemical and biological engineering at Northwestern University, where he has appointments in the Weinberg College of Arts and Sciences, Northwestern University Feinberg School of Medicine and McCormick School of Engineering. He also is the director of the International Institute for Nanotechnology.

“We are excited to congratulate Professor Mirkin on this very prestigious award, indeed the highest honor from ACS, that recognizes his immense contributions to the field of chemistry,” says Mung Chiang, president of Northwestern University. “This latest award further underscores the power of Northwestern scientists to advance the frontiers of human knowledge through research of the highest caliber.”

Dr. Mirkin is only the third professor at Northwestern University to receive this top honor. Tobin J. Marks received the Priestley Medal in 2017, and the late Fred Basolo received it in 2001. Including the three most recent recipients, 24 Priestley Medal laureates have won a Nobel Prize.

The award specifically recognizes Dr. Mirkin “for pioneering contributions to nanochemistry and for impacting the chemistry profession globally through innovations in education, service, and policy at the highest levels, and entrepreneurship.” He will officially receive the award at the society’s Spring 2027 meeting in New Orleans.

​In addition to his fundamental discoveries in chemistry, Dr. Mirkin has invented transformative manufacturing technologies, including molecular printing tools like dip-pen nanolithography, advanced nanofabrication methods, and the world's highest throughput 3D printing tools that are now widely used across research and industry alike. Dr. Mirkin also developed and pioneered high-throughput materials discovery platforms, including nanomaterial megalibraries, that help researchers rapidly identify promising new materials and accelerate innovation. His work in chemistry has reshaped interdisciplinary areas ranging from materials science and catalysis to biology and medicine, with applications spanning healthcare, advanced manufacturing, electronics and clean energy.

“Professor Mirkin has transformed the landscape of nanostructured materials, redefining how chemists design, build and deploy them across diverse scientific and technological domains,” says Joseph S. Francisco, a former ACS president and chemistry professor at University of Pennsylvania. “I can think of no one more deserving of this honor.”

Across more than three decades, Dr. Mirkin’s contributions have extended beyond the laboratory. He has played a leading role in science policy and education, including eight years on the President’s Council of Advisors on Science and Technology, where he helped shape national strategies and policies aimed at improving STEM education and innovation. He also has been an influential global ambassador for chemistry, advancing international collaboration and interdisciplinary research by establishing centers and institutes in Europe, Asia and the Middle East.

A prolific scholar and innovator, Dr. Mirkin has authored more than 940 publications, holds more than 1,470 patent applications worldwide, and has received more than 250 honors, awards and prizes. He also founded 11 companies to commercialize technologies developed in his laboratory, helping to translate fundamental discoveries into more than 2,000 commercial products that benefit society.

Dr. Mirkin’s impact as a mentor and educator is similarly far-reaching. More than 170 of his former students hold faculty positions around the world, and 200 more have become leaders in industry and government.

The Priestley Medal, established in 1922, is awarded annually by ACS to recognize distinguished service to chemistry.

This article was originally published to Northwestern Now on July 17th, 2026.
Picture
Chad A. Mirkin, MD, Professor of Hematology and Oncology

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 844.344.6663
Find an NM oncologist

You May Also Like

Bin Zhang, MD, PHD Headshot

May 2026

ONCOLOGY
Theranostics Provides a Unique Approach to Multidisciplinary Oncology Care
Mazhar Adli, PhD headshot

April 2026

ONCOLOGY
Feinberg Faculty Inducted into Prominent Honor Societies
Huiping Liu, MD, PhD,  headshot

March 2026

ONCOLOGY
Feng Yue, PhD, Named Associate Director for AI and Data Science at Lurie Cancer Center

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2026 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Clinical Breakthroughs
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to Cardiovascular
    • Refer to Kidney Transplant
    • Refer to Neurosciences
    • Refer to Other Specialties